These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 8740338

  • 1. Lodoxamide in vernal keratoconjunctivitis.
    Lee S, Allard TR.
    Ann Pharmacother; 1996 May; 30(5):535-7. PubMed ID: 8740338
    [Abstract] [Full Text] [Related]

  • 2. Mechanisms and comparison of anti-allergic efficacy of topical lodoxamide and cromolyn sodium treatment in vernal keratoconjunctivitis.
    Avunduk AM, Avunduk MC, Kapicioglu Z, Akyol N, Tavli L.
    Ophthalmology; 2000 Jul; 107(7):1333-7. PubMed ID: 10890862
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of lodoxamide 0.1% vs cromolyn sodium 4% in patients with vernal keratoconjunctivitis.
    Caldwell DR, Verin P, Hartwich-Young R, Meyer SM, Drake MM.
    Am J Ophthalmol; 1992 Jun 15; 113(6):632-7. PubMed ID: 1598953
    [Abstract] [Full Text] [Related]

  • 4. Effects of lodoxamide, disodium cromoglycate and fluorometholone on tear leukotriene levels in vernal keratoconjunctivitis.
    Akman A, Irkeç M, Orhan M.
    Eye (Lond); 1998 Jun 15; 12 ( Pt 2)():291-5. PubMed ID: 9683957
    [Abstract] [Full Text] [Related]

  • 5. Comparison of lodoxamide 0.1% ophthalmic solution and levocabastine 0.05% ophthalmic suspension in vernal keratoconjunctivitis.
    Verin P, Allewaert R, Joyaux JC, Piozzi E, Koliopoulos J, Bloch-Michel E, Lodoxamide Study Group.
    Eur J Ophthalmol; 2001 Jun 15; 11(2):120-5. PubMed ID: 11456011
    [Abstract] [Full Text] [Related]

  • 6. Effect of lodoxamide and disodium cromoglycate on tear eosinophil cationic protein in vernal keratoconjunctivitis.
    Leonardi A, Borghesan F, Avarello A, Plebani M, Secchi AG.
    Br J Ophthalmol; 1997 Jan 15; 81(1):23-6. PubMed ID: 9135403
    [Abstract] [Full Text] [Related]

  • 7. Randomised double-masked trial of lodoxamide and sodium cromoglycate in allergic eye disease. A multicentre study.
    Fahy GT, Easty DL, Collum LM, Benedict-Smith A, Hillery M, Parsons DG.
    Eur J Ophthalmol; 1992 Jan 15; 2(3):144-9. PubMed ID: 1450659
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of lodoxamide 0.1% ophthalmic solution in resolving corneal epitheliopathy associated with vernal keratoconjunctivitis.
    Santos CI, Huang AJ, Abelson MB, Foster CS, Friedlaender M, McCulley JP.
    Am J Ophthalmol; 1994 Apr 15; 117(4):488-97. PubMed ID: 8154531
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of lodoxamide 0.1% versus N-acetyl aspartyl glutamic acid 6% ophthalmic solutions in patients with vernal keratoconjunctivitis.
    Gündüz K, Uçakhan O, Budak K, Eryilmaz T, Ozkan M.
    Ophthalmic Res; 1996 Apr 15; 28(2):80-7. PubMed ID: 8792357
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of lodoxamide eye drops on tear fluid cytology of patients with vernal conjunctivitis.
    Oguz H, Bitiren M, Aslan OS, Ozardali I.
    Acta Med Okayama; 1999 Jun 15; 53(3):123-6. PubMed ID: 10410789
    [Abstract] [Full Text] [Related]

  • 11. Safety and efficacy of lodoxamide in vernal keratoconjunctivitis.
    Das D, Khan M, Gul A, Alam R.
    J Pak Med Assoc; 2011 Mar 15; 61(3):239-41. PubMed ID: 21465936
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A clinicopathological analysis of the efficacy of lodoxamide 0.1% eye drops on the conjunctiva of patients with vernal keratoconjunctivitis seen at Guinness Eye Centre, Lagos University Teaching Hospital.
    Adefule-Ositelu AO, Onakoya AO, Olasimbo OO, Adefule AK.
    Niger Postgrad Med J; 2006 Mar 15; 13(1):35-40. PubMed ID: 16633377
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Treatment of common ocular allergic disorders; a comparison of lodoxamide and NAAGA.
    Denis D, Bloch-Michel E, Verin P, Sebastiani A, Tazartes M, Helleboid L, Di Giovanni A, Lecorvec M.
    Br J Ophthalmol; 1998 Oct 15; 82(10):1135-8. PubMed ID: 9924299
    [Abstract] [Full Text] [Related]

  • 17. Pharmacological mechanism of topical lodoxamide treatment in vernal keratoconjunctivitis: a flow-cytometric study.
    Avunduk AM, Avunduk MC, Dayanir V, Tekelioğlu Y, Dayioğlu YS.
    Ophthalmic Res; 1998 Oct 15; 30(1):37-43. PubMed ID: 9483586
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Lodoxamide versus spaglumic acid: a comparative double-blind trial on patients suffering from seasonal allergic conjunctivitis induced by Parietaria pollen.
    Purello D'Ambrosio F, Gangemi S, Ricciardi L, Cuzzocrea S, Di Lorenzo G.
    Allergol Immunopathol (Madr); 1997 Oct 15; 25(5):233-7. PubMed ID: 9395007
    [Abstract] [Full Text] [Related]

  • 20. [Evaluation of efficacy and safety of sterile solution of lodoxamide in patients with ocular allergy].
    Nicoară S.
    Oftalmologia; 2001 Oct 15; 52(2):81-4. PubMed ID: 11771108
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.